Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy

BACKGROUND: Immunotherapy has become a powerful treatment option for several solid tumor types. The presence of tumor-infiltrating lymphocytes (TIL) is correlated with better prognosis in ovarian cancer, pointing at the possibility to benefit from harnessing their anti-tumor activity. This preclinic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Immunol Immunother
Päätekijät: Sakellariou-Thompson, Donastas, Forget, Marie-Andrée, Hinchcliff, Emily, Celestino, Joseph, Hwu, Patrick, Jazaeri, Amir A., Haymaker, Cara, Bernatchez, Chantale
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269372/
https://ncbi.nlm.nih.gov/pubmed/31602489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-019-02402-z
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia